IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.07B
This Quarter Return
+11.32%
1 Year Return
+40.53%
3 Year Return
+328.04%
5 Year Return
+535.34%
10 Year Return
–
AUM
$359M
AUM Growth
+$359M
(+3.2%)
Cap. Flow
-$3.33M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
38.59%
Holding
92
New
21
Increased
23
Reduced
17
Closed
21
Top Buys
| 1 |
McKesson
MCK
|
$13.7M |
| 2 |
Centene
CNC
|
$10.3M |
| 3 |
Abbott
ABT
|
$9.85M |
| 4 |
Biogen
BIIB
|
$8.4M |
| 5 |
AMED
Amedisys
AMED
|
$8.09M |
Top Sells
| 1 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$17.9M |
| 2 |
Medtronic
MDT
|
$10M |
| 3 |
Hologic
HOLX
|
$8.86M |
| 4 |
Zimmer Biomet
ZBH
|
$8.78M |
| 5 |
Acadia Healthcare
ACHC
|
$8.19M |
Sector Composition
| 1 | Healthcare | 97.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
uniQure
QURE
$951M
| $2.07M | 0.57% |
+100,000
| New | +$2.07M |
|
52
Keros Therapeutics
KROS
$638M
| $2.05M | 0.57% |
+35,000
| New | +$2.05M |
|
53
Amicus Therapeutics
FOLD
$2.43B
| $2.02M | 0.56% |
175,000
-250,000
| -59% | -$2.89M |
|
|
IMGN
54
DELISTED
Immunogen Inc
IMGN
| $1.86M | 0.51% |
250,000
-50,000
| -17% | -$371K |
|
55
Akero Therapeutics
AKRO
$3.63B
| $1.8M | 0.5% |
85,000
| – | – |
|
56
PTC Therapeutics
PTCT
$4.37B
| $1.79M | 0.5% |
45,000
-52,100
| -54% | -$2.07M |
|
57
Kiniksa Pharmaceuticals
KNSA
$2.62B
| $1.65M | 0.46% |
+140,000
| New | +$1.65M |
|
58
Mirum Pharmaceuticals
MIRM
$3.74B
| $1.6M | 0.44% |
+100,000
| New | +$1.6M |
|
59
Precision BioSciences
DTIL
$58.8M
| $1.3M | 0.36% |
175,000
+50,000
| +40% | +$370K |
|
|
ICPT
60
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.22M | 0.34% |
+75,000
| New | +$1.22M |
|
61
Kura Oncology
KURA
$723M
| $1.19M | 0.33% |
85,000
+25,000
| +42% | +$350K |
|
62
Alkermes
ALKS
$4.95B
| $1.16M | 0.32% |
+50,000
| New | +$1.16M |
|
63
Lyell Immunopharma
LYEL
$219M
| $1.08M | 0.3% |
140,000
| – | – |
|
|
FMTX
64
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $1.07M | 0.3% |
75,000
+15,000
| +25% | +$213K |
|
65
Lexicon Pharmaceuticals
LXRX
$400M
| $788K | 0.22% |
200,000
-150,000
| -43% | -$591K |
|
|
CMRX
66
DELISTED
Chimerix, Inc.
CMRX
| $707K | 0.2% |
110,000
+20,000
| +22% | +$129K |
|
|
AMRN
67
Amarin Corp
AMRN
$315M
| $674K | 0.19% |
+200,000
| New | +$674K |
|
68
Dianthus Therapeutics
DNTH
$778M
| $399K | 0.11% |
90,000
| – | – |
|
|
MYOV
69
DELISTED
Myovant Sciences Ltd.
MYOV
| $389K | 0.11% |
25,000
-40,000
| -62% | -$622K |
|
|
LBPH
70
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $146K | 0.04% |
30,000
| – | – |
|
71
Agios Pharmaceuticals
AGIO
$2.33B
| – | – |
-20,000
| Closed | -$923K |
|
72
Atea Pharmaceuticals
AVIR
$272M
| – | – |
-30,000
| Closed | -$1.05M |
|
73
BridgeBio Pharma
BBIO
$9.84B
| – | – |
0
| – | – |
|
74
Cencora
COR
$57.1B
| – | – |
-40,000
| Closed | -$4.78M |
|
75
DexCom
DXCM
$30.9B
| – | – |
-10,000
| Closed | -$5.47M |
|